Put Options

16 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$223.92 - $287.77 $3.4 Million - $4.37 Million
-15,200 Reduced 72.38%
5,800 $1.39 Million
Q3 2021

Nov 15, 2021

BUY
$282.99 - $369.05 $2.26 Million - $2.95 Million
8,000 Added 61.54%
21,000 $5.94 Million
Q2 2021

Aug 16, 2021

BUY
$259.0 - $414.71 $932,400 - $1.49 Million
3,600 Added 38.3%
13,000 $4.5 Million
Q4 2020

Feb 16, 2021

SELL
$236.26 - $355.63 $5.13 Million - $7.72 Million
-21,700 Reduced 69.77%
9,400 $2.3 Million
Q3 2020

Nov 16, 2020

BUY
$264.77 - $305.71 $6.06 Million - $7 Million
22,900 Added 279.27%
31,100 $8.82 Million
Q2 2020

Aug 14, 2020

SELL
$258.66 - $342.55 $5.33 Million - $7.06 Million
-20,600 Reduced 71.53%
8,200 $2.19 Million
Q1 2020

May 15, 2020

BUY
$268.85 - $341.04 $107,540 - $136,416
400 Added 1.41%
28,800 $9.11 Million
Q4 2019

Feb 14, 2020

SELL
$220.06 - $304.07 $264,072 - $364,884
-1,200 Reduced 4.05%
28,400 $8.43 Million
Q3 2019

Nov 14, 2019

BUY
$217.44 - $243.88 $2.3 Million - $2.59 Million
10,600 Added 55.79%
29,600 $6.89 Million
Q2 2019

Aug 14, 2019

BUY
$219.29 - $241.72 $3.07 Million - $3.38 Million
14,000 Added 280.0%
19,000 $4.44 Million
Q4 2018

Feb 14, 2019

SELL
$278.5 - $352.75 $2.23 Million - $2.82 Million
-8,000 Reduced 61.54%
5,000 $1.51 Million
Q3 2018

Nov 14, 2018

BUY
$293.51 - $383.83 $3.82 Million - $4.99 Million
13,000 New
13,000 $4.59 Million
Q2 2018

Aug 14, 2018

SELL
$257.52 - $306.91 $4.35 Million - $5.19 Million
-16,900 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$260.13 - $367.91 $3.1 Million - $4.38 Million
11,900 Added 238.0%
16,900 $4.63 Million
Q4 2017

Feb 14, 2018

SELL
$307.64 - $344.58 $4.74 Million - $5.31 Million
-15,400 Reduced 75.49%
5,000 $1.59 Million
Q3 2017

Nov 14, 2017

BUY
$281.15 - $329.69 $5.74 Million - $6.73 Million
20,400
20,400 $6.39 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $25B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.